Latest stories on CAI
CAI Maintained by BTIG -- Price Target Raised to $38.00
GuruFocus63 · neutralanalyst
Caris Life Sciences price target raised to $38 from $33 at BTIG
The Fly64 · neutralanalyst
CAI spotlights AI-driven cancer screening with a Jordan Spieth national commercial for Caris Detect
MarketChameleon61 · neutralproduct/pr
Caris Life Sciences price target raised to $30 from $22 at Canaccord
The Fly64 · neutralanalyst
Caris Life Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026
PR Newswire50 · neutralearnings
CAI rises as Caris previews eight ESMO 2026 studies spanning AI treatment prediction and multi-tumor biomarker research
October 14, 2026
MarketChameleon63 · neutralproduct/pr
Caris Life Sciences to Present Eight Studies Highlighting the Power of AI, Multi-Omics and Precision Medicine at ESMO 2026
PR Newswire58 · neutralproduct/pr
Caris Life Sciences price target raised to $35 from $25 at JPMorgan
The Fly64 · neutralanalyst
CAI Expands Delaware Partnership to Meet New Benefit Accuracy Requirements
Business Insider56 · neutralproduct/pr
CAI Expands Delaware Partnership to Meet New Benefit Accuracy Requirements
GlobeNewswire56 · neutralproduct/pr
Caris Life Sciences price target raised to $36 from $30 at TD Cowen
The Fly64 · neutralanalyst
Caris Life Sciences price target raised to $35 from $23 at BofA
The Fly64 · neutralanalyst
Caris Life Sciences Unveils the Next Evolution of Liquid Biopsy with Enhanced Caris Assure
PR Newswire67 · bullishproduct/pr
Caris Life Sciences Coasts Past A Buy Point; Why This Texas Biotech Researcher Deserves A Look
Investors.com63 · neutralgeneral
Caris Life Sciences: Adjusting My Position After A Recent Steep Incline (Downgrade)
Seeking Alpha52 · neutralanalyst
Caris Life Sciences Stock Jumped 10% Yesterday. Here’s Where Shares Could Go Further in 2026.
Yahoo Top63 · neutralgeneral
Caris Life Sciences: Diagnostics Growth With Room To Run
Seeking Alpha67 · bullishanalyst
Caris Life Sciences, Inc. (CAI) files 8-K
SEC 8-K50 · neutralgeneral
Calian Group initiated with an Outperform at National Bank
The Fly61 · neutralanalyst
Caris Life Sciences initiated with a Neutral at UBS
The Fly50 · neutralanalyst
Caris Life Sciences to present new research at IASCL 2026
The Fly56 · neutralproduct/pr
Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer
PR Newswire65 · bullishproduct/pr
CAI Protective Collar Options for Caris Life Sciences Stock
Barchart50 · neutralgeneral